Unsupervised discovery of clinical disease signatures using probabilistic independence
Open Access
- 23 April 2025
- journal article
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 166, 104837
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Cancer Institute (UL1TR000445)
- National Cancer Institute (CA253923)
- Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona (LCF/BQ/EU22/11930087)
- National Center for Advancing Translational Sciences
This publication has 79 references indexed in Scilit:
- Identifiability of latent-variable and structural-equation models: from linear to nonlinearAnnals of the Institute of Statistical Mathematics, 2023
- The potential use of simvastatin for cancer treatment: A reviewBiomedicine & Pharmacotherapy, 2021
- Budesonide/Glycopyrronium/Formoterol: A Review in COPDDrugs, 2021
- Phenotypic Subtypes of OSAChest, 2020
- Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung CancerChest, 2019
- BPH: Why Do Patients Fail Medical Therapy?Current Urology Reports, 2019
- Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter MedicationsJAMA Network Open, 2018
- Features of COPD as Predictors of Lung CancerChest, 2018
- COPD, emphysema and the onset of lung cancer. A systematic reviewCancer Letters, 2016
- Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugsCancer, 2003